Metabolomic profiling of HepG2/C3A liver-on-chip model exposed to oleic acid, palmitic acid and oleic/palmitic acids mixture
Abstract
Metabolic dysfunction associated steatotic liver disease (MASLD) is one of the most predominant liver disorders. MASLD is associated with dietary intake of fatty acids. Among them, oleic (OA) and palmitic (PA) acids are the most abundant. Furthermore, OA was reported to have an hepatoprotective effect against PA toxicity on primary hepatocytes and liver cell lines. In this work, to characterize the mechanisms related to fatty acids exposure, we analyzed the metabolomic signatures of HepG2/C3A using advanced organ-on-chip technology. The cells were exposed for 2 to 7 days to OA, PA and OA/PA mixture. The cell secretions were analyzed using GC-MS spectrometry to reveal their metabolomic signatures. We were able to identify a common HepG2/C3A response to OA, PA and OA/PA deciphering the FFAs global perturbations including the nitrogen metabolism, after 7 days of treatments. Then, we extracted the specificity of each treatment. We found that OA altered intracellular lipid secretion, while OA/PA shifted metabolism from the lipid production to their consumption. PA exposure induced changes consistent with a perturbation in oxidative stress, energy metabolism and a high oxalic acid production. Nicotinamide levels increased in all treatments, indicating a potential in vitro exposure biomarker of FFA, and a potential mechanistic candidate for further validation in preclinical and clinical settings as its protective effect against liver steatosis was reported in literature. These findings highlight the intricate metabolic responses to FFAs exposure in hepatocytes, suggesting potential biomarkers and pathways for liver-related disorders.
Related
- Metabolomic profiling reveals candidate discriminatory metabolites in stable chronic obstructive pulmonary disease and acute exacerbation
- Metabolomic profiling identifies plasma protein biomarkers of biological aging
- Untargeted Metabolomic Profiling of Spermatozoa and Seminal Plasma Identifies Candidate Metabolic Indicators of Semen Quality in Holstein Bulls.
- Gene expression, Antioxidant Responses, and metabolomic Profiling Reveal Chlorella vulgaris Mediated Protection against acetaminophen and microplastic Co-toxicity in Oreochromis niloticus
- Plasma metabolomic profiling of frailty in older adults at risk of dementia
BibTeX
@article{morisseau2026metabolomic,
title = {{Metabolomic profiling of HepG2/C3A liver-on-chip model exposed to oleic acid, palmitic acid and oleic/palmitic acids mixture}},
author = {Lisa Morisseau and Françoise Gilard and Bertrand Gakière and Cécile Legallais and Yasuyuki Sakai and Eric Leclerc and Rachid Jellali},
journal = {NAM Journal},
year = {2026},
month = sep,
doi = {10.1016/j.namjnl.2026.100122},
url = {https://hal.science/hal-05763569v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Metabolomic profiling of HepG2/C3A liver-on-chip model exposed to oleic acid, palmitic acid and oleic/palmitic acids mixture
AU - Lisa Morisseau
AU - Françoise Gilard
AU - Bertrand Gakière
AU - Cécile Legallais
AU - Yasuyuki Sakai
AU - Eric Leclerc
AU - Rachid Jellali
PY - 2026
DA - 2026/09/25
JO - NAM Journal
DO - 10.1016/j.namjnl.2026.100122
UR - https://hal.science/hal-05763569v1
AB - Metabolic dysfunction associated steatotic liver disease (MASLD) is one of the most predominant liver disorders. MASLD is associated with dietary intake of fatty acids. Among them, oleic (OA) and palmitic (PA) acids are the most abundant. Furthermore, OA was reported to have an hepatoprotective effect against PA toxicity on primary hepatocytes and liver cell lines. In this work, to characterize the mechanisms related to fatty acids exposure, we analyzed the metabolomic signatures of HepG2/C3A using advanced organ-on-chip technology. The cells were exposed for 2 to 7 days to OA, PA and OA/PA mixture. The cell secretions were analyzed using GC-MS spectrometry to reveal their metabolomic signatures. We were able to identify a common HepG2/C3A response to OA, PA and OA/PA deciphering the FFAs global perturbations including the nitrogen metabolism, after 7 days of treatments. Then, we extracted the specificity of each treatment. We found that OA altered intracellular lipid secretion, while OA/PA shifted metabolism from the lipid production to their consumption. PA exposure induced changes consistent with a perturbation in oxidative stress, energy metabolism and a high oxalic acid production. Nicotinamide levels increased in all treatments, indicating a potential in vitro exposure biomarker of FFA, and a potential mechanistic candidate for further validation in preclinical and clinical settings as its protective effect against liver steatosis was reported in literature. These findings highlight the intricate metabolic responses to FFAs exposure in hepatocytes, suggesting potential biomarkers and pathways for liver-related disorders.
SN - 3050-6204
ER -